Disease Spectrum and Predictors of Prolonged Hospitalization in Lebanese Children With COVID-19

Hadi Fakih1,2, Ibrahim Dia3, Mohamad Jawad H Akach4

  • 1Pediatrics, Faculty of Medical Sciences, Lebanese University, Beirut, LBN.

Cureus
|December 15, 2025
PubMed

Insights

Most hospitalized children with COVID-19 experienced mild illness. Radiological pneumonia and the need for anti-inflammatory or antimicrobial treatments were linked to longer hospital stays in Lebanon.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Pediatric COVID-19 often presents mildly, but severe outcomes like multisystem inflammatory syndrome in children (MIS-C) can occur.
  • Limited data exists on pediatric COVID-19 hospitalizations in Lebanon.
  • This study addresses the scarcity of information on clinical features and hospitalization duration for children with COVID-19 in Lebanon.

Purpose of the Study:

  • To describe the clinical characteristics of pediatric COVID-19 hospitalizations in Lebanon.
  • To identify factors associated with prolonged length of stay (LOS) in hospitalized children with COVID-19.
  • To inform clinical risk stratification and resource planning in similar settings.

Main Methods:

  • Retrospective, observational study at Sheikh Ragheb Harb University Hospital.
  • Inclusion of 127 patients under 18 years hospitalized with confirmed COVID-19 (January-December 2021).
  • Data collection on demographics, clinical presentation, labs, imaging, treatment, and outcomes; bivariate and multivariable analyses for LOS predictors.

Main Results:

  • Median age was 0.6 years; 66.1% were male. Common symptoms included fever (71.7%) and cough (52.0%).
  • Only 3.9% required ICU admission or oxygen therapy; one case (0.8%) of MIS-C was reported. No mortality.
  • Median LOS was 3 days. Factors associated with longer LOS included pulmonary consolidation, oxygen requirement, ICU admission, and use of antibiotics and steroids.

Conclusions:

  • The majority of hospitalized children with COVID-19 had mild disease.
  • Radiological pneumonia and the need for anti-inflammatory or antimicrobial therapies were independent predictors of extended hospitalization.
  • Findings support targeted early interventions and resource planning for pediatric COVID-19 management in resource-limited settings.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
698
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
756
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
726
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K